Core Viewpoint - Zhonghui Biotech-B (02627.HK) announced a global offering of 33,442,600 H-shares at a final offer price of HKD 12.90 per share, resulting in a net proceeds of HKD 383 million [1] Summary by Categories Global Offering Details - The Hong Kong public offering accounted for 11.95% of the total global offering, with a subscription rate of 4,007.64 times [1] - The international offering represented 88.05% of the total global offering, with a subscription rate of 0.99 times [1] Trading Information - Assuming the global offering becomes unconditional on August 11, 2025, the H-shares are expected to commence trading on the Hong Kong Stock Exchange at 9:00 AM (Hong Kong time) on the same day [1] - H-shares will be traded in board lots of 200 shares, with the stock code being 2627 [1]
中慧生物-B(02627.HK)香港IPO发行价定为每股12.9港元 净筹3.83亿港元